BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-12-12

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-12	Common Stock	M	5000	$12.99	Acquired	172691	Direct
2012-12-12	Common Stock	S	5000	$50.00	Disposed	167691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-12	Stock Option (right to buy) Common Stock	$12.99	M	5000	Disposed	2016-05-10	Common Stock (5000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on November 12, 2012.

F2: Original option grant vests 6/48th on November 11, 2006 and 1/48th on the 11th day of every month thereafter.